We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Randomized phase III study of cisplatin with or without raltitrexed in patients with malignant pleural mesothelioma: an intergroup study of the European Organisation for Research and Treatment of Cancer Lung Cancer Group and the National Cancer Institute of Canada.
- Authors
van Meerbeeck, Jan P; Gaafar, Rabab; Manegold, Christian; Van Klaveren, Rob J; Van Marck, Eric A; Vincent, Mark; Legrand, Catherine; Bottomley, Andrew; Debruyne, Channa; Giaccone, Giuseppe; European Organisation for Research and Treatment of Cancer Lung Cancer Group; National Cancer Institute of Canada
- Abstract
We conducted a phase III trial to determine whether first-line treatment with raltitrexed, a thymidine synthase inhibitor, and cisplatin results in superior outcome compared with cisplatin alone in patients with malignant pleural mesothelioma (MPM).
- Publication
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2005, Vol 23, Issue 28, p6881
- ISSN
0732-183X
- Publication type
Journal Article
- DOI
10.1200/JCO.20005.14.589